0001209191-16-145735.txt : 20161012
0001209191-16-145735.hdr.sgml : 20161012
20161012180703
ACCESSION NUMBER: 0001209191-16-145735
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20161010
FILED AS OF DATE: 20161012
DATE AS OF CHANGE: 20161012
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GENOMIC HEALTH INC
CENTRAL INDEX KEY: 0001131324
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 770552594
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 301 PENOBSCOT DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
BUSINESS PHONE: 650-556-9300
MAIL ADDRESS:
STREET 1: 301 PENOBSCOT DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cole G Bradley
CENTRAL INDEX KEY: 0001337798
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-51541
FILM NUMBER: 161933813
MAIL ADDRESS:
STREET 1: 301 PENOBSCOT DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-10-10
0
0001131324
GENOMIC HEALTH INC
GHDX
0001337798
Cole G Bradley
301 PENOBSCOT DRIVE
REDWOOD CITY
CA
94063
0
1
0
0
COO
Common Stock
2016-10-10
4
M
0
4000
18.89
A
39426
D
Common Stock
2016-10-10
4
S
0
4000
30.6756
D
35426
D
Common Stock
2016-10-10
4
M
0
4290
23.31
A
39716
D
Common Stock
2016-10-10
4
S
0
4290
30.5058
D
35426
D
Employee Stock Option (right to buy)
18.89
2016-10-10
4
M
0
4000
0.00
D
2016-11-30
Common Stock
0
0
D
Employee Stock Option (right to buy)
23.31
2016-10-10
4
M
0
4290
0.00
D
2017-12-06
Common Stock
0
25710
D
These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on March 7, 2016.
Represents weighted average sale price. Actual sale prices ranged from $30.32 to $30.83.
Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
Includes an aggregate of 18,690 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on June 8, 2016.
Represents weighted average sale price. Actual sale prices ranged from $30.07 to $30.75.
The option became exercisable as to 25% of the shares on November 30, 2007, and became exercisable as to 1/48th of the shares each full month thereafter.
The option became exercisable as to 25% of the shares on December 6, 2008, and became exercisable as to 1/48th of the shares each full month thereafter.
/s/ Jason W. Radford, Attorney-in-fact
2016-10-12